Ebola

Investigators observed that, when compared with the general population of Guinea, survivors of Ebola had a 5-fold increased risk of mortality over a mean of 1 year of follow-up after discharge.

The Biomedical Advanced Research and Development Authority will contribute $23 million for Merck to continue manufacturing the Ebola vaccine over the next year.

The first Contagion® Connect podcast features a conversation with Dr. Alexandra Phelan about the impact of pandemic bonds in the ongoing Ebola outbreak in the DRC.

Variances in collection and siloed efforts are hurting this outbreak response.

The research team deciphered that the nitazoxanide boosts the ability of specific viral sensors to detect Ebola when infected, which then sparks an antiviral immune response.

An independent monitoring board recommended early termination of the PALM trial after determining that 2 of the 4 experimental therapies were linked with better rates of survival.

The Ad26.ZEBOV, MVA-BN-Filo vaccine regimen will be evaluated in an open-label, single-arm study of 800 participants, including frontline health care workers.

August 1, 2019, marks the 1 year anniversary of the North Kivu Ebola outbreak.

From vaccines to conflict, here's an update on why this Ebola outbreak is so unique.

Dr. Tedros has accepted the World Health Organization (WHO) International Health Regulations Emergency Committee's recommendation.

The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.

A new matrix will help prepare multiple industries to combat potential Ebola occupational exposures

The neighboring nation to the DRC has also launched ring vaccination following the confirmation of 3 travel-associated Ebola cases.

This case is the first confirmed case of Ebola that Uganda has detected during the ongoing outbreak in the neighboring Democratic Republic of the Congo.

As the DRC records 2000 cases of Ebola, Contagion® spoke with Krutika Kuppalli, MD, about how this outbreak is unique and whether there is an end in sight.

The latest on this ever-changing and complex outbreak.

As Ebola case counts continue to climb in the ongoing outbreak, emergency preparedness simulations are underway in Uganda.

Designated frontline hospitals were expected to identify, isolate, and hold an Ebola patient for 12-24 hours, but an analysis cites gaps in biopreparedness in these facilities.

Timothy Minogue, PhD, discusses his presentation on miRNAs for Ebola and the capabilities of the host profiling side and the pathogen-derived side.

Ebola virus survivors experience ongoing symptoms following infection, and a new study tracks how those patients compare in health with close contacts who weren’t infected.

An intradermal Ebola vaccine candidate shows promise as a safe, temperature-stable, and effective option for preventing outbreaks, new data show.

Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.

A new study reports that many health care workers had the ability to neutralize the Ebola virus, despite never exhibiting symptoms of infection.

Investigators have detected the presence of Ebola in a bat in Liberia, revealing more about how bats serve as reservoirs for the deadly pathogen.

A new report shows improvement in some areas but a vast gap in US health care readiness still exists.